Pet vaccines are big business these days. Anyone who has ever taken a pet to a veterinarian knows full well that the biggest topic of conversation is typically the slew of pet vaccines needed or mandatorily enforced.
It stands to reason that the pet vaccine market would be experiencing some rather explosive growth. A new Veterinary Vaccines Market report is providing us with a look at how much-expected growth the pet vaccine industry should see over the next few years. The report covers growth expectations from now until 2021. The report concentrates on “CAGR, drivers, opportunities, challenges, vendors, regions, product type, applications” as the basis for its estimates.
Veterinary Vaccines Industry is projected to display growth at CAGR of 4.81% during 2017-2021.
Here are a list of the top pharmaceutical companies that are well-placed to take home the spoils: Elanco, Merck, Merial, Zoetis, Advaxis, AmpliPhi Biosciences, Aratana Therapeutics, ARKO Labs, Bayer, CanFel Therapeutics, Ceva Animal Health, Colorado Serum Company, Epitopix, Genus, Hygieia Biological Laboratories, ImmuCell, Nexvet, Nuovo Biologics, UBI, Valneva, Vetoquinol, and Virbac,
You can view more information on the report here.
If you have a pet, you certainly aren’t surprised to learn of this uptrend. It is also likely to prompt a worsening situation in terms of vet visits with your pet.